These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Withdrawal syndrome associated with abrupt discontinuation of SSRIs. Wincor MZ J Am Pharm Assoc (Wash); 1998; 38(4):500-1. PubMed ID: 9707961 [No Abstract] [Full Text] [Related]
29. Re: Depression, stroke diagnosis, and SSRI discontinuation syndrome. Haddad PM; Dursun SM Can J Psychiatry; 2004 May; 49(5):343-4; author reply 345-6. PubMed ID: 15198473 [No Abstract] [Full Text] [Related]
30. Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient. Kotzalidis GD; de Pisa E; Patrizi B; Savoja V; Ruberto G; Girardi P J Psychopharmacol; 2008 Jul; 22(5):581-4. PubMed ID: 18208915 [TBL] [Abstract][Full Text] [Related]
36. Serotonin discontinuation syndrome: does it really exist? Nuss S; Kincaid CR W V Med J; 2000; 96(2):405-7. PubMed ID: 10771628 [TBL] [Abstract][Full Text] [Related]
37. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder. Foster RH; Goa KL CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224 [TBL] [Abstract][Full Text] [Related]
38. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation. Bogetto F; Bellino S; Revello RB; Patria L CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110 [TBL] [Abstract][Full Text] [Related]